CAMRYN PREJEAN: Open Payments
NPI 1366119919 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 8 companies in 2025. Trend: 2023 $486 · 2024 $362 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Davol Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $44 |
| Dilon Technologies, Inc. | 1 | $39 |
| HISTOSONICS, INC. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Alcresta Therapeutics, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: OMVOH, HEMOBLAST BELLOWS, Phasix Mesh, Channel Drain, ZENPEP, Exparel, RELIZORB, JOURNAVX.
Industry payments across TX — which companies pay providers there.
